Synthesis of a novel series of 6-chloro-1,4,2-benzodithiazine 1,1-dioxide derivatives with potential biological activity

Journal of Heterocyclic Chemistry

Volumn 42, Issue 7, 2005, Pages 1297-1303

  Brzozowski, Z ^a   Saczewski F ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,2 BENZODITHIAZINE DERIVATIVE; 2 (6 CHLORO 7 METHYL 1,1 DIOXO 2,3 DIHYDRO 1,4,2 BENZODITHIAZIN 3 YL)PHENOL; 6 CHLORO 1,4,2 BENZODITHIAZINE 1,1 DIOXIDE DERIVATIVE; 6 CHLORO 3 (2 HYDROXYPHENYL) 7 METHYL 2,3 DIHYDRO 1,4,2 BENZODITHIAZINE 1,1 DIOXIDE; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CELL LINE; TUMOR GROWTH;

EID: 28244457852     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570420708     Document Type: Article

References (21)

1. Z. Brzozowski and J. Sławiński, Acta Polon. Pharm., 41, 5 (1984).
2. Z. Brzozowski and J. Sławiński, Acta Polon. Pharm., 41, 133 (1984).
3. Z. Brzozowski, F. Gajewski, J. Sławiński and E. Pomarnacka, Acta Polon. Pharm. Drug Res., 50, 199 (1993).
4. Z. Brzozowski, Acta Polon. Pharm., Drug Res., 55, 473 (1998).
5. Z. Brzozowski and F. Saczewski, Eur. J. Med. Chem., 37, 285 (2002).
6. Z. Brzozowski and F. Saczewski, J. Med. Chem., 45, 430 (2002).
7. E. Pomarnacka, Acta Polon. Pharm. Drug Res., 55, 481 (1998).
8. Z. Brzozowski, Acta Polon. Pharm. Drug Res., 52, 91 (1995).
9. E. Pomarnacka and M. Gdaniec, Bioorg. Med. Chem., 11, 1259 (2003).
10. Z. Brzozowski, F. Sa̧czewski and M. Gdaniec, Bioorg. Med. Chem., 11, 3673 (2003).
11. T. Iwokawa, H. Tamura, A. Murabayashi and Y. Hayase, Chem. Pharm. Bull., 39. 1939 (1991).
12. S.W. Wright, J. Heterocyclic Chem., 38, 723 (2001).
13. Z. Brzozowski, J. Sławiński, F. Gajewski, S. Angielski and A. Hoppe. Acta Polon. Pharm. 42, 413 (1985).
14. Z. Brzozowski, J. Sławiński, W. Janiec, U. Cegła, L. Śliwiński and I., Sedlak, Acta Polon. Pharm. Drug. Res., 49, 75 (1992).
15. Z. Brzozowski, Acta Polon. Pharm., Drug Res., 54, 293 (1997).
16. Z. Brzozowski, F. Saczewski and M. Gdaniec, Eur. J. Med. Chem., 38, 991 (2003).
17. Z. Brzozowski, F. Saczewski, T. Sanchez, L. Ch. Kuo, M Gdaniec and N. Neamati, Bioorg. Med. Chem., 12, 3663 (2004).
18. Z. Brzozowski, Acta Polon. Pharm., 44, 486 (1987).
19. M. R. Boyd. Am. Assoc. Cancer Res., 30, 652 (1989).
20. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Poull, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Combell, J. Mayo and M. Boyd, J. Natl. Cancer Inst., 83, 757 (1991).
21. I. N. Weinstein, T. G. Myers, P. M. O'Conner, S. H. Friend, A. J. Jr Fornance, K. W. Kohn, T. Fojo, S. E. Bates, L. V. Robinstein, J. K. Buolamwini, W. W. van Osdol, A. P. Monks, D. A. Scudiero, E. A. Sausiville, D. Zaharevitz, B. Bunow, V. N. Viswanadhan, G. S. Johnson, R. E. Wittes and K. D. Paull, Science 275, 343 (1997).